@article{5f2f1b1172ec4d1e842d6a271f81fd12,
title = "Letter to the Editor about Sorich et al.",
author = "Laura Mezquita and Edouard Auclin and Benjamin Besse",
note = "Funding Information: Disclosure: Dr. Mezquita reports acting in a consulting and advisory role for Roche Diagnostics; conducting lectures and educational activities for Bristol-Myers Squibb, Tecnofarma, and Roche; receiving reimbursement for travel, accommodations, and expenses from Chugai and Roche; and particpating in a mentorship program with key opinion leaders that was funded by AstraZeneca. Dr. Besse reports conducting sponsored research at Gustave Roussy Cancer Center with funding from AbbVie, Amgen, AstraZeneca, Biogen, Blueprint Medicines, BMS, Celgene, Eli Lilly, GSK, Ignyta, IPSEN, Merck KGaA, MSD, Nektar, Onxeo, Pfizer, Pharma Mar, Sanofi, Spectrum Pharmaceuticals, Takeda, and Tiziana Pharma. The remaining author declares no conflict of interest.",
year = "2019",
month = sep,
day = "1",
doi = "10.1016/j.jtho.2019.05.022",
language = "English",
volume = "14",
pages = "e209",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
number = "9",
}